CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
and carboplatin in locally advanced unresectable or metastatic triple-negative breast cancer.The main questions i...
Phase 2
Charlotte, North Carolina, United States
doxorubicin and cyclophosphamide (AC) or epirubicin and cyclophosphamide (EC). Usually, after neoadjuvant therapy and surgery for triple ne ...
Phase 3
Charlotte, North Carolina, United States and 216 other locations
previously untreated, locally advanced, inoperable or metastatic triple-negative breast cancer whose tumors...
Phase 3
Charlotte, North Carolina, United States and 374 other locations
for patients with previously untreated, locally advanced, unresectable or metastatic (Stage IV) programmed death-ligand 1 (PD-L1)-positive triple...
Phase 2
Charlotte, North Carolina, United States and 39 other locations
This is a Phase III, randomised, open-label, 2 arm, multicentre, international study assessing the efficacy and safety of Dato-DXd compared with ICC...
Phase 3
Charlotte, North Carolina, United States and 226 other locations
(ABBV-181) and/or chemotherapy in participants with selected solid tumors. This study consists of 2 main parts, a dose-escalation phase and ...
Phase 1
Huntersville, North Carolina, United States of America and 26 other locations
with stage I to III TNBC with residual invasive disease in the breast and/or axillary lymph nodes at surgical resection following neoadjuvan...
Phase 3
Charlotte, North Carolina, United States and 275 other locations
to treatment of physician's choice (TPC) in participants with triple-negative breast cancer (TNBC) who received n...
Phase 3
Charlotte, North Carolina, United States and 244 other locations
Cancer is a condition where cells in a specific part of body grow and reproduce uncontrollably. Non-Small Cell Lung Cancer (NSCLC) ...
Phase 1
Huntersville, North Carolina, United States of America and 33 other locations
or in combination with pembrolizumab at treating participants' cancer. This will be done by measuring the number of participants who respond...
Phase 1
Huntersville, North Carolina, United States and 1 other location
Clinical trials
Research sites
Resources
Legal